United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 2, 2026 · Filed Apr 6, 2026

On Apr 2, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$561.50 for US$5.61M under a trading plan, leaving 18,876 shares. Filed Apr 6, 2026 (Form 4).

Sold
10,000 shares
Price
US$561.50 average (US$551.86 to US$571.65)
Value
US$5.61M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 2, 2026Common StockSale40US$551.8628,836Direct
Apr 2, 2026Common StockSale401US$553.9928,435Direct
Apr 2, 2026Common StockSale778US$555.2227,657Direct
Apr 2, 2026Common StockSale844US$556.1726,813Direct
Apr 2, 2026Common StockSale977US$557.0525,836Direct
Apr 2, 2026Common StockSale720US$558.1125,116Direct
Apr 2, 2026Common StockSale240US$559.0324,876Direct
Apr 2, 2026Common StockSale72US$560.3924,804Direct
Apr 2, 2026Common StockSale571US$561.7524,233Direct
Apr 2, 2026Common StockSale555US$563.0023,678Direct
Apr 2, 2026Common StockSale896US$563.8622,782Direct
Apr 2, 2026Common StockSale2,201US$564.8220,581Direct
Apr 2, 2026Common StockSale742US$565.9919,839Direct
Apr 2, 2026Common StockSale323US$566.8219,516Direct
Apr 2, 2026Common StockSale400US$567.9519,116Direct
Apr 2, 2026Common StockSale120US$569.7518,996Direct
Apr 2, 2026Common StockSale120US$571.6518,876Direct

Source

View original at SEC

Related